| Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
|---|
| 04/28/2009 | US7524367 beneficial for use in a dye (photosensitizer) sensitized solar cell capable of being extensively sensitized to a near infrared region from the visible light region; to improve an energy conversion efficiency; ink |
| 04/28/2009 | CA2562251C Pyrazolo'4,3-d pyrimidines |
| 04/28/2009 | CA2510853C Pyrrolopyrimidine derivatives |
| 04/28/2009 | CA2472954C Aza-arylpiperazines |
| 04/28/2009 | CA2400176C Substituted piperazine compounds |
| 04/28/2009 | CA2346396C 4,5-dihydro-isoxazole derivatives and their pharmaceutical use |
| 04/23/2009 | WO2009051504A1 Benzo- and pyridopyridazinones with analgesic and antiinflammatory activity |
| 04/23/2009 | WO2009051399A2 Novel compounds of reverse turn mimetics and the use thereof (1) |
| 04/23/2009 | WO2009051398A2 Novel compounds of reverse turn mimetics and the use thereof (2) |
| 04/23/2009 | WO2009051397A2 Novel compounds of reverse turn mimetics and the use thereof (3) |
| 04/23/2009 | WO2009051162A1 Method for producing bicyclo ring compound |
| 04/23/2009 | WO2009049731A1 Imidazo[1,2-a]pyrimidine derivatives for treating diseases such as diabetes |
| 04/23/2009 | WO2009002423A3 Polycyclic guanine derivatives and use thereof |
| 04/23/2009 | WO2008131501A3 New anti-viral nucleoside analogs |
| 04/23/2009 | WO2008008704A3 Inhibitors of cyclic nucleotide synthesis and their use for therapy of various diseases |
| 04/23/2009 | WO2006138453A3 Compositions and methods pertaining to pna synthons and oligomers comprising a universal base |
| 04/23/2009 | WO2005089067A3 Screening of anti-viral drugs and pharmaceutical compositions containing thiazolidinone derivatives |
| 04/23/2009 | US20090105289 11beta-hydroxysteroid dehydrogenase type 1 active spiro compounds |
| 04/23/2009 | US20090105284 Aminocyclohexanes as Dipeptidyl Peptidase-IV for the Treatment or Prevention of Diabetes |
| 04/23/2009 | US20090105267 Octahydro-pyrrolo[3,4-b]pyrrole n-oxides |
| 04/23/2009 | US20090105263 Heterobicyclic compounds as glucokinase activators |
| 04/23/2009 | US20090105261 Novel substituted pyrazolo[1,5<I>A</I>]-1,3,5-Triazine derivatives and their analogues, pharmaceutical compositions containing same, use thereof as medicine and methods for preparing same |
| 04/23/2009 | US20090105259 Acyclic 1,4-Diamines and Uses Thereof |
| 04/23/2009 | US20090105243 for treating p38 kinase-associated conditions like inflammatory disorders; improved dissolution rate and oral bioavailability; rheumatic diseases; skin disorders; multiple sclerosis; osteoporosis; Alzheimer's disease |
| 04/23/2009 | US20090105229 Purine derivatives as kinase inhibitors |
| 04/23/2009 | US20090105228 Heterocyclic benzodiazepine cgrp receptor antagonists |
| 04/23/2009 | US20090105227 Thienopyrroles As Antiviral Agents |
| 04/23/2009 | US20090105219 Spirolactam Tricyclic CGRP Receptor Antagonists |
| 04/23/2009 | US20090105215 Heterocyclic compounds, methods for the preparation thereof, and uses thereof |
| 04/23/2009 | US20090105210 Bicyclic Pyrimidines as Dipeptidyl Peptidase-IV Inhibitors for the Treatment or Prevention of Diabetes |
| 04/23/2009 | DE102007050673A1 New hexaaza-acene compounds comprising three pyrazine-annelated and additional benzo-annelated rings, useful as fluorescence dye in biochemical medical diagnostics, and as transistor in organic semiconductor technology |
| 04/23/2009 | DE102007049883A1 Diketopyrrolopyrrol-Mischkristalle Diketopyrrolopyrrole solid solutions |
| 04/23/2009 | DE102007048716A1 Imidazo[1,2-a]pyrimidinderivate Imidazo [1,2-a] pyrimidine derivatives |
| 04/23/2009 | CA2702281A1 Imidazo[1,2-a]pyrimidine derivatives |
| 04/22/2009 | EP2050751A1 Compounds specific to adenosine A1 and A3 receptors and uses thereof |
| 04/22/2009 | EP2050750A2 Multicyclic compounds and their use as inhibitors of PARP, VEGFR2 and MLK3 enzymes |
| 04/22/2009 | EP2050749A1 Pyrimidine derivative as pi3k inhibitor and use thereof |
| 04/22/2009 | EP2050748A1 Novel fused pyrimidines |
| 04/22/2009 | EP2050449A1 Aqueous liquid preparation containing amide compound |
| 04/22/2009 | EP2049544A2 Purinone derivatives as hm74a agonists |
| 04/22/2009 | EP2049543A1 Acyclic amine inhibitors of 5'-methylthioadenosine phosphorylase and nucleosidase |
| 04/22/2009 | EP2049542A1 Pyrrolotriazine kinase inhibitors |
| 04/22/2009 | EP2049541A2 Fused heterocyclic derivative and use thereof |
| 04/22/2009 | EP2049540A1 4-amino-3-arylamino-6-arylpyrazolo[3,4-d]pyrimidine derivatives, methods for their preparation and their use as antiviral agents |
| 04/22/2009 | EP2049539A1 Pyrazolopyrimidines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same. |
| 04/22/2009 | EP2049519A2 Cyclic derivatives as modulators of chemokine receptor activity |
| 04/22/2009 | EP2049486A2 Piperidinyl derivatives as modulators of chemokine receptor activity |
| 04/22/2009 | EP2049481A2 Novel compounds as antagonists or inverse agonists for opioid receptors |
| 04/22/2009 | EP1718651B1 7h-pyrrolopyrimidine derivatives |
| 04/22/2009 | EP1539761B1 6,7-dihydro-5h-pyrazolo¬1,2-a pyrazol-1-ones which control inflammatory cytokines |
| 04/22/2009 | CN101415713A Novel spiro [imidazolidine-4, 3' -indole] 2, 2', 5' (1H) triones for treatment of conditions associated with vanilloid receptor 1 |
| 04/22/2009 | CN101415712A Use of spiro imidazolidine-4, 3'-indole-2, 2', 5' (1H) triones for treatment of conditions associated with vanilloid receptor 1 |
| 04/22/2009 | CN101415711A Novel spiro [imidazolidine-4, 3 '-indole] 2,2', 5' (1'H) triones for treatment of conditions associated with vanilloid receptor 1 |
| 04/22/2009 | CN101415710A Bicyclic imidazole or thiadiazole heterocycles useful as selective androgen receptor modulators |
| 04/22/2009 | CN101415709A Octahydro-pyrrolo[3,4-b]pyrrole derivatives |
| 04/22/2009 | CN101415705A Compounds and methods for inhibiting hepatitis c viral replication |
| 04/22/2009 | CN101415419A Novel imidazolopyrazole derivatives useful as selective androgen receptor modulators |
| 04/22/2009 | CN101412721A 6,13-substituted pentacene and derivatives thereof, as well as preparation |
| 04/22/2009 | CN101412651A Pentacenes and derivatives thereof, as well as thereof |
| 04/22/2009 | CN100480248C Malonamide derivatives as gamma-secretase inhibitors |
| 04/21/2009 | US7521552 Process for preparation of substituted amino alcohols |
| 04/21/2009 | US7521551 Chlorins possessing fused ring systems useful as photoselective compounds for photodynamic therapy |
| 04/21/2009 | US7521464 drugs have beta-amyloid peptide production inhibitory activity, such as 2-(2-benzo[b]thiophen-4-yl-acetylamino)-N-(5-phenyl-2H-pyrazol-3-yl)-propionamide, useful for treatment of Alzheimer's disease and Down's Syndrome |
| 04/21/2009 | US7521455 Histamine H3 receptor antagonist or inverse agonist activity; metabolic diseases, circulatory diseases, or nervous system diseases; e.g. 3-(4-((1-cyclobutyl-4-piperidinyl)oxy)phenyl)-2-ethylpyrido(2,3-d)pyrimidin-4(3H)-one |
| 04/21/2009 | US7521450 Inhibitors of kinases |
| 04/21/2009 | US7521447 2-aza-[4.3.0]bicyclic heteroaromatic rings; useful for the treatment of inflammation, osteoarthritis, rheumatoid arthritis, psoriasis, Crohn's disease, inflammatory bowel disease, cancer, autoimmune diseases, and for the treatment of other cytokine-mediated diseases |
| 04/21/2009 | US7521441 8-Cyclohexyl-1,1a,2,12b-tetrahydro-1a-(4-morpholinylcarbonyl)-cycloprop[d]indolo[2,1-a][2]benzazepine-5-carboxylic acid, methyl ester; RNA polymerase, HCV metalloprotease, HCV serine protease, HCV polymerase, HCV helicase inhibitor; liver disease, including cirrhosis and hepatocellular carcinoma |
| 04/21/2009 | US7521158 High sensitivity without residues in a unexposed portion, capable of forming a rectangular fine pattern and excellent in heat fastness and light fastness; high cost performance, for solid photographing element; alkali-soluble binder, solvent-soluble dye, photopolymerization initiator |
| 04/21/2009 | US7521062 Thiosemicarbazones as anti-virals and immunopotentiators |
| 04/21/2009 | US7520982 Cucurbituril-containing polymer, stationary phase and column using the same |
| 04/21/2009 | CA2182949C Compounds for the treatment of disorders related to vasculogenesis and/or angiogenesis |
| 04/16/2009 | WO2009049111A1 2-((r)-2-methylpyrrolidin-2-yl)-1h-benzimidazole-4-carboxamide crystalline form 1 |
| 04/16/2009 | WO2009049109A1 2-((r)-2-methylpyrrolidin-2-yl)-1h-benzimidazole-4-carboxamide crystalline form 2 |
| 04/16/2009 | WO2009049028A1 Pyrrolopyrimidine compounds and their use as janus kinase modulators |
| 04/16/2009 | WO2009047563A1 Pyrrolo [2, 3 -d] pyrimidin derivatives as protein kinase b inhibitors |
| 04/16/2009 | WO2009047522A1 Bicyclic heterocyclic compounds as protein tyrosine kinase inhibitors |
| 04/16/2009 | WO2009047506A1 Bicyclic heterocyclic compounds as protein tyrosine kinase inhibitors |
| 04/16/2009 | WO2009047359A1 Inhibitors of protein kinases |
| 04/16/2009 | WO2009047255A1 Heterobicyclic compounds as histamine h4-receptor antagonists |
| 04/16/2009 | WO2009047104A2 Pyrrolopyrrole derivatives, their manufacture and use |
| 04/16/2009 | WO2009046624A1 Preparation methods of (4s,5r)-semi-esters |
| 04/16/2009 | WO2009021992A3 Fused bicyclic pyrimidines |
| 04/16/2009 | WO2009016516A8 Cytotoxic agents comprising new tomaymycin derivatives and their therapeutic use |
| 04/16/2009 | WO2008153947A3 Heterocyclic compounds as raf kinase modulators |
| 04/16/2009 | WO2008142250A3 Process for preparing porphyrin derivatives, such as protoporphyrin (ix) and synthesis intermediate |
| 04/16/2009 | WO2008047952A3 Antidepressant, neuroprotectant, amyloid beta deposition inhibitor or age retardant containing heterocyclic compound |
| 04/16/2009 | WO2006104917A3 Process for preparing pyrido[2,3-d]pyrimidin-7-one and 3,4-dihydropyrimido[4,5-d]pyrimidin-2(1h)-one derivatives |
| 04/16/2009 | US20090099359 Eszopiclone process |
| 04/16/2009 | US20090099357 Agent for the prevention and treatment of prostatic hyperplasia comprising pyrazolopyrimidinone compound |
| 04/16/2009 | US20090099235 Pyrazolopyrrolidines as Inhibitors of Gamma Secretase |
| 04/16/2009 | US20090099195 Therapeutic Compounds 570 |
| 04/16/2009 | US20090099190 Kinase inhibitors useful for the treatment of proliferative diseases |
| 04/16/2009 | US20090099171 Diazaquinolones that inhibit prolyl hydroxylase activity |
| 04/16/2009 | US20090099168 HIV Integrase inhibitors |
| 04/16/2009 | US20090099167 Organic compounds |
| 04/16/2009 | US20090099165 Protein Kinase Inhibitors |
| 04/16/2009 | US20090099153 Novel 8,10-diaza-bicyclo[4.3.1]decane derivatives and their medical use |
| 04/16/2009 | US20090098181 Triazolopyridazines as kinase modulators |
| 04/16/2009 | US20090098086 Thienopyrimidine and pyrazolopyrimidine compounds and their use as mtor kinase and pi3 kinase inhibitors |
| 04/16/2009 | US20090098084 Parp inhibitor compounds, compositions and methods of use |